Search

everythinglearnresearchcommunity

for

Search:↓

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

The POMP gene is active in various goat tissues and affects hair growth, with certain treatments influencing its expression.

Injections improve hair growth, density, and thickness in women safely.

Platelet-rich plasma is used for facial and hair treatments, showing benefits despite varying methods and limited research.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

L-Lysine may help with various health conditions, but results are inconsistent for herpes treatment and its potential in other therapies is still being explored.

Activated platelet-rich plasma helps hair growth by boosting growth factors and cell growth pathways in hair cells.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

PRP therapy is a promising hair loss treatment for people with alopecia.

PRP treatment helps hair growth and density in androgenetic alopecia patients.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

PRP injections may be an effective treatment for severe hair loss.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A new method effectively analyzes Finasteride and its impurities, even under stress conditions.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Platelet-rich plasma (PRP) effectively improves skin aging with minimal risk.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

New biomarkers and potential treatments for skin diseases were identified.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

SFRP2 and PTGDS may be key factors in female hair loss.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

The two finasteride formulations are bioequivalent.

PRP injections significantly improve hair regrowth in alopecia areata.

PRP-exosomes improve hair growth and reduce inflammation.